{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:46:35Z","timestamp":1787028395676,"version":"build-2736575974"},"reference-count":226,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2016,3,9]],"date-time":"2016-03-09T00:00:00Z","timestamp":1457481600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>The pathogenesis of type 2 diabetes (T2D) involves chronic hyperinsulinemia due to systemic and hepatic insulin resistance (IR), which if uncorrected, will lead to progressive pancreatic beta cell failure in predisposed individuals. Non-alcoholic fatty liver disease (NAFLD) encompasses a spectrum of fatty (simple steatosis and steatohepatitis) and non-fatty liver changes (NASH-cirrhosis with or without hepatocellular carcinoma (HCC)) that are commonly observed among individuals with multiple metabolic derangements, notably including visceral obesity, IR and T2D. Hepatitis C virus (HCV) infection is also often associated with both hepatic steatosis and features of a specific HCV-associated dysmetabolic syndrome. In recent years, the key role of the steatotic liver in the development of IR and T2D has been increasingly recognized. Thus, in this comprehensive review we summarize the rapidly expanding body of evidence that links T2D with NAFLD and HCV infection. For each of these two liver diseases with systemic manifestations, we discuss the epidemiological burden, the pathophysiologic mechanisms and the clinical implications. To date, substantial evidence suggests that NAFLD and HCV play a key role in T2D development and that the interaction of T2D with liver disease may result in a \u201cvicious circle\u201d, eventually leading to an increased risk of all-cause mortality and liver-related and cardiovascular complications. Preliminary evidence also suggests that improvement of NAFLD is associated with a decreased incidence of T2D. Similarly, the prevention of T2D following HCV eradication in the era of direct-acting antiviral agents is a biologically plausible result. However, additional studies are required for further clarification of mechanisms involved.<\/jats:p>","DOI":"10.3390\/ijms17030355","type":"journal-article","created":{"date-parts":[[2016,3,9]],"date-time":"2016-03-09T10:38:02Z","timestamp":1457519882000},"page":"355","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":40,"title":["Type 2 Diabetes in Non-Alcoholic Fatty Liver Disease and Hepatitis C Virus Infection\u2014Liver: The \u201cMusketeer\u201d in the Spotlight"],"prefix":"10.3390","volume":"17","author":[{"given":"Stefano","family":"Ballestri","sequence":"first","affiliation":[{"name":"Operating Unit Internal Medicine, Pavullo General Hospital, Azienda USL Modena, ViaSuore di San Giuseppe Benedetto Cottolengo, 5, Pavullo, 41026 Modena, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1051-1272","authenticated-orcid":false,"given":"Fabio","family":"Nascimbeni","sequence":"additional","affiliation":[{"name":"Outpatient Liver Clinic and Operating Unit Internal Medicine, NOCSAE, Azienda USL Modena, Via P. Giardini, 1355, 41126 Modena, Italy"},{"name":"Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Via P. Giardini, 1355, 41126 Modena, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dante","family":"Romagnoli","sequence":"additional","affiliation":[{"name":"Outpatient Liver Clinic and Operating Unit Internal Medicine, NOCSAE, Azienda USL Modena, Via P. Giardini, 1355, 41126 Modena, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrica","family":"Baldelli","sequence":"additional","affiliation":[{"name":"Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Via P. Giardini, 1355, 41126 Modena, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4325-3900","authenticated-orcid":false,"given":"Giovanni","family":"Targher","sequence":"additional","affiliation":[{"name":"Section of Endocrinology, Diabetes and Metabolism, Department of Medicine, University and Azienda Ospedaliera Universitaria Integrata of Verona, Piazzale Stefani, 1, 37126 Verona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9886-0698","authenticated-orcid":false,"given":"Amedeo","family":"Lonardo","sequence":"additional","affiliation":[{"name":"Outpatient Liver Clinic and Operating Unit Internal Medicine, NOCSAE, Azienda USL Modena, Via P. Giardini, 1355, 41126 Modena, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2016,3,9]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1056\/NEJMcp1103643","article-title":"Clinical practice. Diagnosis of diabetes","volume":"367","author":"Inzucchi","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1016\/S0140-6736(15)60971-0","article-title":"Care of diabetes in children and adolescents: Controversies, changes, and consensus","volume":"385","author":"Cameron","year":"2015","journal-title":"Lancet"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.dld.2014.09.020","article-title":"Nonalcoholic fatty liver disease: Aprecursor of the metabolic syndrome","volume":"47","author":"Lonardo","year":"2015","journal-title":"Dig. Liver Dis."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.jhep.2013.05.044","article-title":"From NAFLD in clinical practice to answers from guidelines","volume":"59","author":"Nascimbeni","year":"2013","journal-title":"J. Hepatol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1016\/j.jhep.2014.12.012","article-title":"NAFLD: A multisystem disease","volume":"62","author":"Byrne","year":"2015","journal-title":"J. Hepatol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.dld.2015.10.027","article-title":"A \u201csystems medicine\u201d approach to the study of non-alcoholic fatty liver disease","volume":"48","author":"Petta","year":"2016","journal-title":"Dig. Liver Dis."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1365-2893.2005.00669.x","article-title":"Hepatitis C and steatosis: A reappraisal","volume":"13","author":"Lonardo","year":"2006","journal-title":"J. Viral Hepat."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1053\/j.gastro.2015.08.035","article-title":"Extrahepatic morbidity and mortality of chronic hepatitis C","volume":"149","author":"Negro","year":"2015","journal-title":"Gastroenterology"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.diabres.2009.10.007","article-title":"Global estimates of the prevalence of diabetes for 2010 and 2030","volume":"87","author":"Shaw","year":"2010","journal-title":"Diabetes Res. Clin. Pract."},{"key":"ref_10","unstructured":"Kanavos, P., van den Aardweg, S., and Schurer, W. Diabetes Expenditure, Burden of Disease and Management in 5 EU Countries. Available online: http:\/\/www.lse.ac.uk\/LSEHealthAndSocialCare\/research\/LSEHealth\/MTRG\/LSEDiabetesReport26Jan2012.pdf."},{"key":"ref_11","unstructured":"Centers for Disease Control and Prevention (2011). National Diabetes Fact Sheet: National Estimates and General Information on Diabetes and Prediabetes in the United States."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"American Diabetes Association (2008). Economic costs of diabetes in the U.S. in 2007. Diabetes Care, 31, 596\u2013615.","DOI":"10.2337\/dc08-9017"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"4293","DOI":"10.1210\/jc.2012-3487","article-title":"Year in diabetes 2012: The diabetes tsunami","volume":"97","author":"Sherwin","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_14","first-page":"922","article-title":"Studies on the liver in diabetes mellitus. II. The significance of fatty metamorphosis and its correlation with insulin sensitivity","volume":"36","author":"Zimmerman","year":"1950","journal-title":"J. Lab. Clin. Med."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Ballestri, S., Nascimbeni, F., Romagnoli, D., and Lonardo, A. (2016). The independent predictors of NASH and its individual histological features. Insulin resistance, serum uric acid, metabolic syndrome, alt and serum total cholesterol are a clue to pathogenesis and candidate targets for treatment. Hepatol. Res.","DOI":"10.1016\/j.dld.2015.07.032"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Zhang, Y., Zhang, T., Zhang, C., Tang, F., Zhong, N., Li, H., Song, X., Lin, H., Liu, Y., and Xue, F. (2015). Identification of reciprocal causality between non-alcoholic fatty liver disease and metabolic syndrome by a simplified bayesian network in a chinese population. BMJ Open, 5.","DOI":"10.1136\/bmjopen-2015-008204"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"617","DOI":"10.3109\/07853890.2010.518623","article-title":"Meta-analysis: Natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity","volume":"43","author":"Musso","year":"2011","journal-title":"Ann. Med."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Ballestri, S., Zona, S., Targher, G., Romagnoli, D., Baldelli, E., Nascimbeni, F., Roverato, A., Guaraldi, G., and Lonardo, A. (2015). Nonalcoholic fatty liver disease is associated with an almost two-fold increased risk of incident type 2 diabetes and metabolic syndrome. Evidence from a systematic review and meta-analysis. J. Gastroenterol. Hepatol.","DOI":"10.1111\/jgh.13264"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.jhep.2008.08.006","article-title":"Hepatitis Cinfection and risk of diabetes: A systematic review and meta-analysis","volume":"49","author":"White","year":"2008","journal-title":"J. Hepatol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"S165","DOI":"10.1016\/j.dld.2014.10.005","article-title":"Extrahepatic manifestations of chronic hepatitis Cvirus infection","volume":"46","author":"Cacoub","year":"2014","journal-title":"Dig. Liver Dis."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1053\/j.gastro.2003.11.020","article-title":"Steatosis and hepatitis Cvirus: Mechanisms and significance for hepatic and extrahepatic disease","volume":"126","author":"Lonardo","year":"2004","journal-title":"Gastroenterology"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/liv.13027","article-title":"Direct-acting antivirals for the treatment of hepatitis Cvirus infection: Optimizing current IFN-free treatment and future perspectives","volume":"36","author":"Asselah","year":"2016","journal-title":"Liver Int."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.mcna.2013.10.011","article-title":"An overview of emerging therapies for the treatment of chronic hepatitis C","volume":"98","author":"Ilyas","year":"2014","journal-title":"Med. Clin. N. Am."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"i36","DOI":"10.1136\/gutjnl-2012-302144","article-title":"New direct-acting antiviral agents for the treatment of hepatitis Cvirus infection and perspectives","volume":"61","author":"Welsch","year":"2012","journal-title":"Gut"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/j.1872-034X.2012.01031.x","article-title":"Liver and diabetes. A vicious circle","volume":"43","author":"Loria","year":"2013","journal-title":"Hepatol. Res."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Ballestri, S., Nascimbeni, F., Romagnoli, D., Baldelli, E., and Lonardo, A. (2016). The role of nuclear receptors in the pathophysiology, natural course, and drug treatment of NAFLDin humans. Adv. Ther.","DOI":"10.1007\/s12325-016-0306-9"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.dld.2015.10.016","article-title":"Treatment of type 2 diabetes mellitus by viral eradication in chronic hepatitis C: Myth or reality?","volume":"48","author":"Vanni","year":"2016","journal-title":"Dig. Liver Dis."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"E1141","DOI":"10.1152\/classicessays.00043.2006","article-title":"Muscle, liver, and pancreas: Three musketeers fighting to control glycemia","volume":"291","author":"Klip","year":"2006","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/BF02369347","article-title":"The fourth musketeer\u2014From Alexandre Dumas to Claude Bernard","volume":"38","author":"Reaven","year":"1995","journal-title":"Diabetologia"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1002\/hep.26717","article-title":"Extrahepatic complications of nonalcoholic fatty liver disease","volume":"59","author":"Armstrong","year":"2014","journal-title":"Hepatology"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s11739-011-0609-4","article-title":"Is nonalcoholic steatohepatitis associated with a high-though-normal thyroid stimulating hormone level and lower cholesterol levels?","volume":"8","author":"Carulli","year":"2013","journal-title":"Intern. Emerg. Med."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.dld.2013.09.018","article-title":"Inflammatory hepatocellular adenomatosis, metabolic syndrome, polycystic ovary syndrome and non-alcoholic steatohepatitis: Chance tetrad or association by necessity?","volume":"46","author":"Nascimbeni","year":"2014","journal-title":"Dig. Liver Dis."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1038\/nrgastro.2009.33","article-title":"Endocrine and liver interaction: The role of endocrine pathways in NASH","volume":"6","author":"Loria","year":"2009","journal-title":"Nat.Rev. Gastroenterol. Hepatol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s12020-015-0640-8","article-title":"Evidence that non-alcoholic fatty liver disease and polycystic ovary syndrome are associated by necessity rather than chance: Anovel hepato-ovarian axis?","volume":"51","author":"Targher","year":"2016","journal-title":"Endocrine"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1007\/s40618-015-0315-6","article-title":"Nonalcoholic fatty liver disease and decreased bone mineral density: Is there a link?","volume":"38","author":"Targher","year":"2015","journal-title":"J. Endocrinol. Investig."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"217","DOI":"10.3390\/ijms17020217","article-title":"Relationship between non-alcoholic fatty liver disease and psoriasis: A novel hepato-dermal axis?","volume":"17","author":"Mantovani","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.gtc.2015.07.006","article-title":"Extrahepatic manifestations of hepatitis C virus","volume":"44","author":"Vigano","year":"2015","journal-title":"Gastroenterol. Clin. N. Am."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"S69","DOI":"10.1016\/j.jhep.2014.08.003","article-title":"Facts and fictions of HCV and comorbidities: Steatosis, diabetes mellitus, and cardiovascular diseases","volume":"61","author":"Negro","year":"2014","journal-title":"J. Hepatol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/j.dld.2015.08.004","article-title":"Epidemiological modifiers of non-alcoholic fatty liver disease: Focus on high-risk groups","volume":"47","author":"Lonardo","year":"2015","journal-title":"Dig Liver Dis."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.cgh.2014.04.014","article-title":"Fibrosis progression in nonalcoholic fatty liver vs nonalcoholic steatohepatitis: Asystematic review and meta-analysis of paired-biopsy studies","volume":"13","author":"Singh","year":"2015","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1111\/j.1478-3231.2011.02482.x","article-title":"Histopathological stages of nonalcoholic fatty liver disease in type 2 diabetes: Prevalences and correlated factors","volume":"31","author":"Leite","year":"2011","journal-title":"Liver Int."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1210\/jc.2015-1966","article-title":"High prevalence of nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus and normal plasma aminotransferase levels","volume":"100","author":"Bril","year":"2015","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1053\/j.gastro.2010.09.038","article-title":"Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: Aprospective study","volume":"140","author":"Williams","year":"2011","journal-title":"Gastroenterology"},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Kwok, R., Choi, K.C., Wong, G.L., Zhang, Y., Chan, H.L., Luk, A.O., Shu, S.S., Chan, A.W., Yeung, M.W., and Chan, J.C. (2015). Screening diabetic patients for non-alcoholic fatty liver disease with controlled attenuation parameter and liver stiffness measurements: Aprospective cohort study. Gut.","DOI":"10.1136\/gutjnl-2015-309265"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/nrgastro.2013.41","article-title":"Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis","volume":"10","author":"Anstee","year":"2013","journal-title":"Nat.Rev. Gastroenterol. Hepatol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1002\/hep.27395","article-title":"The role of liver fat and insulin resistance as determinants of plasma aminotransferase elevation in nonalcoholic fatty liver disease","volume":"61","author":"Maximos","year":"2015","journal-title":"Hepatology"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"3637","DOI":"10.1210\/jc.2013-1519","article-title":"Resolution of fatty liver and risk of incident diabetes","volume":"98","author":"Sung","year":"2013","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.2337\/dc15-0140","article-title":"Independent association between improvement of nonalcoholic fatty liver disease and reduced incidence of type 2 diabetes","volume":"38","author":"Yamazaki","year":"2015","journal-title":"Diabetes Care"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/liv.12912","article-title":"The impact of non-alcoholic fatty liver disease on incident type 2 diabetes mellitus in non-overweight individuals","volume":"36","author":"Fukuda","year":"2016","journal-title":"Liver Int."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.atherosclerosis.2015.07.018","article-title":"Liver fat, statin use, and incident diabetes: The multi-ethnic study of atherosclerosis","volume":"242","author":"Shah","year":"2015","journal-title":"Atherosclerosis"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1002\/hep.21327","article-title":"Long-term follow-up of patients with NAFLD and elevated liver enzymes","volume":"44","author":"Ekstedt","year":"2006","journal-title":"Hepatology"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"548","DOI":"10.4239\/wjd.v6.i4.548","article-title":"Adipose tissue fibrosis","volume":"6","author":"Buechler","year":"2015","journal-title":"World J. Diabetes"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.cmet.2013.06.016","article-title":"Fibrosis and adipose tissue dysfunction","volume":"18","author":"Sun","year":"2013","journal-title":"Cell Metab."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1172\/JCI45887","article-title":"Adipose tissue remodeling and obesity","volume":"121","author":"Sun","year":"2011","journal-title":"J. Clin. Investig."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1194\/jlr.M500294-JLR200","article-title":"Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans","volume":"46","author":"Cinti","year":"2005","journal-title":"J. Lipid Res."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.2337\/diabetes.54.8.2277","article-title":"Reduction of macrophage infiltration and chemoattractant gene expression changes in white adipose tissue of morbidly obese subjects after surgery-induced weight loss","volume":"54","author":"Cancello","year":"2005","journal-title":"Diabetes"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"4467","DOI":"10.1128\/MCB.00192-09","article-title":"Hypoxia-inducible factor 1alpha induces fibrosis and insulin resistance in white adipose tissue","volume":"29","author":"Halberg","year":"2009","journal-title":"Mol. Cell. Biol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"2484","DOI":"10.2337\/db11-0174","article-title":"Disruption of hypoxia-inducible factor 1 in adipocytes improves insulin sensitivity and decreases adiposity in high-fat diet-fed mice","volume":"60","author":"Jiang","year":"2011","journal-title":"Diabetes"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1128\/MCB.00951-12","article-title":"Selective inhibition of hypoxia-inducible factor 1alpha ameliorates adipose tissue dysfunction","volume":"33","author":"Sun","year":"2013","journal-title":"Mol. Cell. Biol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1172\/JCI29881","article-title":"Obesity induces a phenotypic switch in adipose tissue macrophage polarization","volume":"117","author":"Lumeng","year":"2007","journal-title":"J. Clin. Investig."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"3239","DOI":"10.2337\/db08-0872","article-title":"Phenotypic switching of adipose tissue macrophages with obesity is generated by spatiotemporal differences in macrophage subtypes","volume":"57","author":"Lumeng","year":"2008","journal-title":"Diabetes"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1507\/endocrj.EJ12-0271","article-title":"Adipose tissue inflammation and ectopic lipid accumulation","volume":"59","author":"Suganami","year":"2012","journal-title":"Endocr. J."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1161\/01.RES.0000163635.62927.34","article-title":"Adipose tissue, inflammation, and cardiovascular disease","volume":"96","author":"Berg","year":"2005","journal-title":"Circ. Res."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/nrcardio.2009.55","article-title":"Obesity, inflammation, and atherosclerosis","volume":"6","author":"Rocha","year":"2009","journal-title":"Nat. Rev. Cardiol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1126\/science.7678183","article-title":"Adipose expression of tumor necrosis factor-\u03b1: Direct role in obesity-linked insulin resistance","volume":"259","author":"Hotamisligil","year":"1993","journal-title":"Science"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1038\/39335","article-title":"Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function","volume":"389","author":"Uysal","year":"1997","journal-title":"Nature"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1172\/JCI26498","article-title":"Mcp-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity","volume":"116","author":"Kanda","year":"2006","journal-title":"J. Clin. Investig."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"26602","DOI":"10.1074\/jbc.M601284200","article-title":"Overexpression of monocyte chemoattractant protein-1 in adipose tissues causes macrophage recruitment and insulin resistance","volume":"281","author":"Kamei","year":"2006","journal-title":"J. Biol. Chem."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1172\/JCI24335","article-title":"CCR2 modulates inflammatory and metabolic effects of high-fat feeding","volume":"116","author":"Weisberg","year":"2006","journal-title":"J. Clin. Investig."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1038\/90984","article-title":"The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity","volume":"7","author":"Yamauchi","year":"2001","journal-title":"Nat. Med."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/nm724","article-title":"Diet-induced insulin resistance in mice lacking adiponectin\/ACRP 30","volume":"8","author":"Maeda","year":"2002","journal-title":"Nat. Med."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.cmet.2014.05.005","article-title":"Adipocyte inflammation is essential for healthy adipose tissue expansion and remodeling","volume":"20","author":"Tao","year":"2014","journal-title":"Cell Metab."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.2337\/db10-0585","article-title":"Fibrosis in human adipose tissue: Composition, distribution, and link with lipid metabolism and fat mass loss","volume":"59","author":"Divoux","year":"2010","journal-title":"Diabetes"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1172\/JCI77812","article-title":"The pathogenesis of insulin resistance: Integrating signaling pathways and substrate flux","volume":"126","author":"Samuel","year":"2016","journal-title":"J. Clin. Investig."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"50230","DOI":"10.1074\/jbc.M200958200","article-title":"Mechanism by which fatty acids inhibit insulin activation of insulin receptor substrate-1 (IRS-1)-associated phosphatidylinositol 3-kinase activity in muscle","volume":"277","author":"Yu","year":"2002","journal-title":"J. Biol. Chem."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.2337\/diabetes.48.6.1270","article-title":"Free fatty acid-induced insulin resistance is associated with activation of protein kinase Ctheta and alterations in the insulin signaling cascade","volume":"48","author":"Griffin","year":"1999","journal-title":"Diabetes"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"9597","DOI":"10.1073\/pnas.1409229111","article-title":"Role of diacylglycerol activation of PKC\u03b8 in lipid-induced muscle insulin resistance in humans","volume":"111","author":"Szendroedi","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1111\/jgh.12227","article-title":"Severity of non-alcoholic steatohepatitis is associated with substitution of adipose tissue in skeletal muscle","volume":"28","author":"Kitajima","year":"2013","journal-title":"J. Gastroenterol. Hepatol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"23163","DOI":"10.3390\/ijms151223163","article-title":"Irisin, a link among fatty liver disease, physical inactivity and insulin resistance","volume":"15","author":"Ranchal","year":"2014","journal-title":"Int. J. Mol. Sci."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/nature10777","article-title":"A PGC 1-\u03b1-dependent myokine that drives brown-fat-like development of white fat and thermogenesis","volume":"481","author":"Bostrom","year":"2012","journal-title":"Nature"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1042\/BJ20130457","article-title":"Brown adipose tissue: Development, metabolism and beyond","volume":"453","author":"Schulz","year":"2013","journal-title":"Biochem. J."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1038\/nature07182","article-title":"PRDM16 controls a brown fat\/skeletal muscle switch","volume":"454","author":"Seale","year":"2008","journal-title":"Nature"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1126\/science.1190816","article-title":"Medicine. Beige can be slimming","volume":"328","author":"Ishibashi","year":"2010","journal-title":"Science"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1056\/NEJMcibr0809610","article-title":"The origins of brown adipose tissue","volume":"360","author":"Enerback","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"ref_85","doi-asserted-by":"crossref","unstructured":"Scheja, L., and Heeren, J. (2016). Metabolic interplay between white, beige, brown adipocytes and the liver. J. Hepatol.","DOI":"10.1016\/j.jhep.2016.01.025"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1172\/JCI13103","article-title":"Brown adipose tissue-specific insulin receptor knockout shows diabetic phenotype without insulin resistance","volume":"108","author":"Guerra","year":"2001","journal-title":"J. Clin. Investig."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/nm.2297","article-title":"Brown adipose tissue activity controls triglyceride clearance","volume":"17","author":"Bartelt","year":"2011","journal-title":"Nat. Med."},{"key":"ref_88","first-page":"22","article-title":"Irisin in the glucose continuum","volume":"124","author":"Assyov","year":"2016","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.jdiacomp.2013.03.002","article-title":"Lower circulating irisin is associated with type 2 diabetes mellitus","volume":"27","author":"Liu","year":"2013","journal-title":"J. Diabetes Complicat."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.jhep.2013.04.030","article-title":"Irisin is inversely associated with intrahepatic triglyceride contents in obese adults","volume":"59","author":"Zhang","year":"2013","journal-title":"J. Hepatol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1172\/JCI23621","article-title":"Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease","volume":"115","author":"Donnelly","year":"2005","journal-title":"J. Clin. Investig."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1146\/annurev-physiol-021115-105331","article-title":"Pathophysiology and mechanisms of nonalcoholic fatty liver disease","volume":"78","author":"Haas","year":"2016","journal-title":"Ann. Rev. Physiol."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"3023","DOI":"10.1210\/jcem.87.7.8638","article-title":"Fat accumulation in the liver is associated with defects in insulin suppression of glucose production and serum free fatty acids independent of obesity in normal men","volume":"87","author":"Vehkavaara","year":"2002","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1007\/s00125-005-1682-x","article-title":"Insulin resistance in non-diabetic patients with non-alcoholic fatty liver disease: Sites and mechanisms","volume":"48","author":"Bugianesi","year":"2005","journal-title":"Diabetologia"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1073\/pnas.1423952112","article-title":"Insulin-independent regulation of hepatic triglyceride synthesis by fatty acids","volume":"112","author":"Vatner","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"560","DOI":"10.2337\/diabetes.53.3.560","article-title":"Insulin-independent induction of sterol regulatory element-binding protein-1c expression in the livers of streptozotocin-treated mice","volume":"53","author":"Matsuzaka","year":"2004","journal-title":"Diabetes"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1172\/JCI37385","article-title":"Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight\/obese humans","volume":"119","author":"Stanhope","year":"2009","journal-title":"J. Clin. Investig."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.cmet.2006.06.008","article-title":"Carbohydrate response element binding protein, chrebp, a transcription factor coupling hepatic glucose utilization and lipid synthesis","volume":"4","author":"Uyeda","year":"2006","journal-title":"Cell Metab."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1210\/en.2012-1725","article-title":"The role of the carbohydrate response element-binding protein in male fructose-fed rats","volume":"154","author":"Erion","year":"2013","journal-title":"Endocrinology"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.cmet.2009.01.011","article-title":"The role of peroxisome proliferator-activated receptor gamma coactivator-1 \u03b2 in the pathogenesis of fructose-induced insulin resistance","volume":"9","author":"Nagai","year":"2009","journal-title":"Cell Metab."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1194\/jlr.M049130","article-title":"Liver Xreceptor regulates hepatic nuclear O-GlcNAc signaling and carbohydrate responsive element-binding protein activity","volume":"56","author":"Bindesboll","year":"2015","journal-title":"J. Lipid Res."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/j.cell.2012.02.017","article-title":"Mechanisms for insulin resistance: Common threads and missing links","volume":"148","author":"Samuel","year":"2012","journal-title":"Cell"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1002\/hep.21655","article-title":"Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis","volume":"45","author":"Yamaguchi","year":"2007","journal-title":"Hepatology"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1172\/JCI30400","article-title":"Inhibition of protein kinase cepsilon prevents hepatic insulin resistance in nonalcoholic fatty liver disease","volume":"117","author":"Samuel","year":"2007","journal-title":"J. Clin. Investig."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1677\/joe.0.1620207","article-title":"Tissue and isoform-selective activation of protein kinase Cin insulin-resistant obese zucker rats\u2014Effects of feeding","volume":"162","author":"Qu","year":"1999","journal-title":"J. Endocrinol."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"16381","DOI":"10.1073\/pnas.1113359108","article-title":"Cellular mechanism of insulin resistance in nonalcoholic fatty liver disease","volume":"108","author":"Kumashiro","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1053\/j.gastro.2012.03.003","article-title":"Intrahepatic diacylglycerol content is associated with hepatic insulin resistance in obese subjects","volume":"142","author":"Magkos","year":"2012","journal-title":"Gastroenterology"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"24202","DOI":"10.1074\/jbc.274.34.24202","article-title":"Ceramide generation is sufficient to account for the inhibition of the insulin-stimulated PKBpathway in C2C12 skeletal muscle cells pretreated with palmitate","volume":"274","author":"Craig","year":"1999","journal-title":"J. Biol. Chem."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"36608","DOI":"10.1074\/jbc.M406499200","article-title":"Regulation of insulin action by ceramide: Dual mechanisms linking ceramide accumulation to the inhibition of AKT\/protein kinase B","volume":"279","author":"Stratford","year":"2004","journal-title":"J. Biol. Chem."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"16880","DOI":"10.1016\/S0021-9258(17)44844-7","article-title":"1,2-Diacylglycerol and ceramide levels in insulin-resistant tissues of the rat in vivo","volume":"265","author":"Turinsky","year":"1990","journal-title":"J. Biol. Chem."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.cmet.2012.04.002","article-title":"A ceramide-centric view of insulin resistance","volume":"15","author":"Chavez","year":"2012","journal-title":"Cell Metab."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.cmet.2014.10.017","article-title":"C16:0-ceramide signals insulin resistance","volume":"20","author":"Hla","year":"2014","journal-title":"Cell Metab."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.cmet.2014.08.002","article-title":"Obesity-induced CERS6-dependent C16:0 ceramide production promotes weight gain and glucose intolerance","volume":"20","author":"Turpin","year":"2014","journal-title":"Cell Metab."},{"key":"ref_114","doi-asserted-by":"crossref","unstructured":"Luukkonen, P.K., Zhou, Y., Sadevirta, S., Leivonen, M., Arola, J., Oresic, M., Hyotylainen, T., and Yki-Jarvinen, H. (2016). Ceramides dissociate steatosis and insulin resistance in the human liver in non-alcoholic fatty liver disease. J. Hepatol.","DOI":"10.1016\/j.jhep.2016.01.002"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"48968","DOI":"10.1074\/jbc.M407841200","article-title":"Identification, cloning, expression, and purification of three novel human calcium-independent phospholipase A2 family members possessing triacylglycerol lipase and acylglycerol transacylase activities","volume":"279","author":"Jenkins","year":"2004","journal-title":"J. Biol. Chem."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1038\/ng.257","article-title":"Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease","volume":"40","author":"Romeo","year":"2008","journal-title":"Nat. Genet."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"2616","DOI":"10.2337\/db09-0279","article-title":"Dissociation between fatty liver and insulin resistance in humans carrying a variant of the patatin-like phospholipase 3 gene","volume":"58","author":"Kantartzis","year":"2009","journal-title":"Diabetes"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1007\/s00125-009-1285-z","article-title":"A common variant in PNPLA3, which encodes adiponutrin, is associated with liver fat content in humans","volume":"52","author":"Kotronen","year":"2009","journal-title":"Diabetologia"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1002\/hep.23768","article-title":"PNPLA3 variants specifically confer increased risk for histologic nonalcoholic fatty liver disease but not metabolic disease","volume":"52","author":"Speliotes","year":"2010","journal-title":"Hepatology"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.cmet.2012.04.008","article-title":"Adiponutrin functions as a nutritionally regulated lysophosphatidic acid acyltransferase","volume":"15","author":"Kumari","year":"2012","journal-title":"Cell Metab."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1002\/hep.27242","article-title":"PNPLA3I148Mknockin mice accumulate PNPLA3 on lipid droplets and develop hepatic steatosis","volume":"61","author":"Smagris","year":"2015","journal-title":"Hepatology"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1002\/hep.27943","article-title":"Potential mechanism underlying the PNPLA3I148M-hepatic steatosis connection","volume":"63","author":"Wu","year":"2016","journal-title":"Hepatology"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1053\/j.gastro.2007.10.039","article-title":"Activation and dysregulation of the unfolded protein response in nonalcoholic fatty liver disease","volume":"134","author":"Puri","year":"2008","journal-title":"Gastroenterology"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1055\/s-0028-1091980","article-title":"Molecular mechanisms of lipotoxicity in nonalcoholic fatty liver disease","volume":"28","author":"Malhi","year":"2008","journal-title":"Semin. Liver Dis."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1038\/nature07976","article-title":"Autophagy regulates lipid metabolism","volume":"458","author":"Singh","year":"2009","journal-title":"Nature"},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1002\/hep.23645","article-title":"Macroautophagy and chaperone-mediated autophagy are required for hepatocyte resistance to oxidant stress","volume":"52","author":"Wang","year":"2010","journal-title":"Hepatology"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"C973","DOI":"10.1152\/ajpcell.00527.2009","article-title":"Autophagy in health and disease. 2. Regulation of lipid metabolism and storage by autophagy: Pathophysiological implications","volume":"298","author":"Czaja","year":"2010","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1038\/nm.2851","article-title":"Fetuin-Aacts as an endogenous ligand of TLR4 to promote lipid-induced insulin resistance","volume":"18","author":"Pal","year":"2012","journal-title":"Nat. Med."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"28324","DOI":"10.1074\/jbc.C113.495473","article-title":"Adipocyte fetuin-Acontributes to macrophage migration into adipose tissue and polarization of macrophages","volume":"288","author":"Chatterjee","year":"2013","journal-title":"J. Biol. Chem."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1161\/CIRCULATIONAHA.105.588723","article-title":"Association between human fetuin-Aand the metabolic syndrome: Data from the heart and soul study","volume":"113","author":"Ix","year":"2006","journal-title":"Circulation"},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1001\/jama.300.2.182","article-title":"Fetuin-Aand incident diabetes mellitus in older persons","volume":"300","author":"Ix","year":"2008","journal-title":"JAMA"},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"853","DOI":"10.2337\/diacare.29.04.06.dc05-1938","article-title":"Alpha2-heremans-schmid glycoprotein\/fetuin-Ais associated with insulin resistance and fat accumulation in the liver in humans","volume":"29","author":"Stefan","year":"2006","journal-title":"Diabetes Care"},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/j.cmet.2015.09.023","article-title":"Fetuin Bis a secreted hepatocyte factor linking steatosis to impaired glucose metabolism","volume":"22","author":"Meex","year":"2015","journal-title":"Cell Metab."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1172\/JCI23606","article-title":"FGF-21 as a novel metabolic regulator","volume":"115","author":"Kharitonenkov","year":"2005","journal-title":"J. Clin. Investig."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.2337\/db07-1476","article-title":"Serum FGF21 levels are increased in obesity and are independently associated with the metabolic syndrome in humans","volume":"57","author":"Zhang","year":"2008","journal-title":"Diabetes"},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"107","DOI":"10.3389\/fendo.2014.00107","article-title":"FGF21 as a hepatokine, adipokine, and myokine in metabolism and diseases","volume":"5","author":"Itoh","year":"2014","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.2337\/dc09-0684","article-title":"Circulating fibroblast growth factor-21 is elevated in impaired glucose tolerance and type 2 diabetes and correlates with muscle and hepatic insulin resistance","volume":"32","author":"Chavez","year":"2009","journal-title":"Diabetes Care"},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1053\/j.gastro.2010.04.054","article-title":"Increased fibroblast growth factor 21 in obesity and nonalcoholic fatty liver disease","volume":"139","author":"Dushay","year":"2010","journal-title":"Gastroenterology"},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.jhep.2012.10.029","article-title":"High serum level of fibroblast growth factor 21 is an independent predictor of non-alcoholic fatty liver disease: A3-year prospective study in china","volume":"58","author":"Li","year":"2013","journal-title":"J. Hepatol."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.jhep.2010.05.018","article-title":"Fibroblast growth factor 21 levels are increased in nonalcoholic fatty liver disease patients and are correlated with hepatic triglyceride","volume":"53","author":"Li","year":"2010","journal-title":"J. Hepatol."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.cmet.2015.12.001","article-title":"SerpinB1 promotes pancreatic beta cell proliferation","volume":"23","author":"Dirice","year":"2016","journal-title":"Cell Metab."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.cmet.2015.12.011","article-title":"Dramatis personae in beta-cell mass regulation: Enter serpinB1","volume":"23","author":"Tarasov","year":"2016","journal-title":"Cell Metab."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1002\/hep.28356","article-title":"The severity of NAFLD is associated with gut dysbiosis and shift in the metabolic function of the gut microbiota","volume":"63","author":"Boursier","year":"2016","journal-title":"Hepatology"},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1136\/gutjnl-2012-303816","article-title":"Intestinal microbiota determines development of non-alcoholic fatty liver disease in mice","volume":"62","author":"Llopis","year":"2013","journal-title":"Gut"},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1097\/MOL.0b013e3283347ebb","article-title":"Gut microbiota as a regulator of energy homeostasis and ectopic fat deposition: Mechanisms and implications for metabolic disorders","volume":"21","author":"Musso","year":"2010","journal-title":"Curr. Opin. Lipidol."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0140-6736(11)60614-4","article-title":"Type 2 diabetes across generations: From pathophysiology to prevention and management","volume":"378","author":"Nolan","year":"2011","journal-title":"Lancet"},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1007\/s00535-012-0653-5","article-title":"Clinicopathological features of liver injury in patients with type 2 diabetes mellitus and comparative study of histologically proven nonalcoholic fatty liver diseases with or without type 2 diabetes mellitus","volume":"48","author":"Shima","year":"2013","journal-title":"J.Gastroenterol."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.bbacli.2014.09.001","article-title":"Clinical spectrum of non-alcoholic fatty liver disease in diabetic and non-diabetic patients","volume":"3","author":"Goh","year":"2015","journal-title":"BBA Clin."},{"key":"ref_149","doi-asserted-by":"crossref","unstructured":"Nascimbeni, F., Aron-Wisniewsky, J., Pais, R., Tordjman, J., Poitou, C., Charlotte, F., Bedossa, P., Poynard, T., Clement, K., and Ratziu, V. (2016). Statins, antidiabetic medications and liver histology in diabetic patients with non-alcoholic fatty liver disease. BMJ Open Gastroenterol., in press.","DOI":"10.1136\/bmjgast-2015-000075"},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1002\/hep.510300604","article-title":"Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis","volume":"30","author":"Angulo","year":"1999","journal-title":"Hepatology"},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.jhep.2006.05.008","article-title":"Diagnostic and predictive factors of significant liver fibrosis and minimal lesions in patients with persistent unexplained elevated transaminases. A prospective multicenter study","volume":"45","author":"Ratziu","year":"2006","journal-title":"J. Hepatol."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1016\/j.cgh.2009.06.007","article-title":"Independent predictors of fibrosis in patients with nonalcoholic fatty liver disease","volume":"7","author":"Hossain","year":"2009","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1007\/s00535-013-0911-1","article-title":"Type 2 diabetes mellitus is associated with the fibrosis severity in patients with nonalcoholic fatty liver disease in a large retrospective cohort of Japanese patients","volume":"49","author":"Nakahara","year":"2014","journal-title":"J. Gastroenterol."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1016\/j.jhep.2014.11.034","article-title":"Evidence of NAFLDprogression from steatosis to fibrosing-steatohepatitis using paired biopsies: Implications for prognosis and clinical management","volume":"62","author":"McPherson","year":"2015","journal-title":"J. Hepatol."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.jhep.2013.04.027","article-title":"A systematic review of follow-up biopsies reveals disease progression in patients with non-alcoholic fatty liver","volume":"59","author":"Pais","year":"2013","journal-title":"J. Hepatol."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.jhep.2004.09.012","article-title":"The histological course of nonalcoholic fatty liver disease: A longitudinal study of 103 patients with sequential liver biopsies","volume":"42","author":"Adams","year":"2005","journal-title":"J. Hepatol."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"284","DOI":"10.2337\/dc09-0148","article-title":"Histological course of nonalcoholic fatty liver disease in Japanese patients: Tight glycemic control, rather than weight reduction, ameliorates liver fibrosis","volume":"33","author":"Hamaguchi","year":"2010","journal-title":"Diabetes Care"},{"key":"ref_158","doi-asserted-by":"crossref","unstructured":"Hashiba, M., Ono, M., Hyogo, H., Ikeda, Y., Masuda, K., Yoshioka, R., Ishikawa, Y., Nagata, Y., Munekage, K., and Ochi, T. (2013). Glycemic variability is an independent predictive factor for development of hepatic fibrosis in nonalcoholic fatty liver disease. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0076161"},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1002\/hep.22429","article-title":"Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: Arole for insulin resistance and diabetes","volume":"48","author":"Fracanzani","year":"2008","journal-title":"Hepatology"},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1586\/17474124.2015.1007955","article-title":"Role of ultrasound in the diagnosis and treatment of nonalcoholic fatty liver disease and its complications","volume":"9","author":"Ballestri","year":"2015","journal-title":"Expert Rev. Gastroenterol. Hepatol."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1159\/000360510","article-title":"Non-alcoholic fatty liver disease: Diagnosis and investigation","volume":"32","author":"Nascimbeni","year":"2014","journal-title":"Dig. Dis."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/S1542-3565(04)00014-X","article-title":"Nonalcoholic fatty liver disease in patients with type 2 diabetes","volume":"2","author":"Younossi","year":"2004","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1097\/MEG.0b013e32833aa19b","article-title":"Metabolic risk factors are a major comorbidity in patients with cirrhosis independent of the presence of hepatocellular carcinoma","volume":"22","author":"Hessheimer","year":"2010","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1002\/ijc.25797","article-title":"Non-alcoholic fatty liver disease progresses to hepatocellular carcinoma in the absence of apparent cirrhosis","volume":"128","author":"Ertle","year":"2011","journal-title":"Int. J.Cancer"},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.cgh.2011.01.023","article-title":"Characteristics of patients with nonalcoholic steatohepatitis who develop hepatocellular carcinoma","volume":"9","author":"Yasui","year":"2011","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"9","DOI":"10.14218\/JCTH.2015.00001","article-title":"Diabetes mellitus predicts occurrence of cirrhosis and hepatocellular cancer in alcoholic liver and non-alcoholic fatty liver diseases","volume":"3","author":"Raff","year":"2015","journal-title":"J. Clin. Transl. Hepatol."},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.cgh.2009.01.001","article-title":"Hepatocellular carcinoma in patients with cryptogenic cirrhosis","volume":"7","author":"Giannini","year":"2009","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1002\/hep.28368","article-title":"HCC-NAFLD Italian Study Group. Clinical patterns of hepatocellular carcinoma (HCC) in nonalcoholic fatty liver disease (NAFLD): Amulticenter prospective study","volume":"63","author":"Piscaglia","year":"2016","journal-title":"Hepatology"},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1038\/ajg.2014.132","article-title":"Mortality from chronic liver diseases in diabetes","volume":"109","author":"Zoppini","year":"2014","journal-title":"Am. J. Gastroenterol."},{"key":"ref_170","unstructured":"Wild, S.H., Morling, J.R., McAllister, D.A., Kerssens, J., Fischbacher, C., Parkes, J., Roderick, P.J., Sattar, N., and Byrne, C.D. (2016). Scottish and Southampton Diabetes and Liver Disease Group and the Scottish Diabetes Research Network Epidemiology Group. Type 2 diabetes, chronic liver disease and hepatocellular cancer: A national retrospective cohort study using linked routine data. J. Hepatol."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1038\/ajg.2010.18","article-title":"Nonalcoholic fatty liver disease increases risk of death among patients with diabetes: A community-based cohort study","volume":"105","author":"Adams","year":"2010","journal-title":"Am. J. Gastroenterol."},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.3748\/wjg.v20.i7.1724","article-title":"Risk of cardiovascular, cardiac and arrhythmic complications in patients with non-alcoholic fatty liver disease","volume":"20","author":"Ballestri","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1586\/17474124.2015.965143","article-title":"Diagnosis and management of cardiovascular risk in nonalcoholic fatty liver disease","volume":"9","author":"Lonardo","year":"2015","journal-title":"Expert Rev. Gastroenterol. Hepatol."},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.2337\/dc07-0349","article-title":"Nonalcoholic fatty liver disease is independently associated with an increased incidence of cardiovascular events in type 2 diabetic patients","volume":"30","author":"Targher","year":"2007","journal-title":"Diabetes Care"},{"key":"ref_175","doi-asserted-by":"crossref","unstructured":"Mantovani, A., Ballestri, S., Lonardo, A., and Targher, G. (2016). Cardiovascular disease and myocardial abnormalities in nonalcoholic fatty liver disease. Dig. Dis. Sci.","DOI":"10.1007\/s10620-016-4040-6"},{"key":"ref_176","unstructured":"Naunyn, B. (1898). Der Diabetes Melitis, A Holder."},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1586\/eri.09.3","article-title":"Hepatitis C and diabetes: The inevitable coincidence?","volume":"7","author":"Lonardo","year":"2009","journal-title":"Expert Rev. Anti. Infect. Ther."},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/S0168-8278(05)80631-2","article-title":"Evidence for a link between hepatitis Cvirus infection and diabetes mellitus in a cirrhotic population","volume":"21","author":"Allison","year":"1994","journal-title":"J. Hepatol."},{"key":"ref_179","unstructured":"Searched on PubMed, Keywords: \u201cHCV and diabetes\u201d, Available online: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/?term=HCV+and+diabetes."},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1001\/jama.2014.7085","article-title":"Treatment of hepatitis C: Asystematic review","volume":"312","author":"Kohli","year":"2014","journal-title":"JAMA"},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/nrgastro.2013.107","article-title":"Epidemiology and natural history of HCVinfection","volume":"10","author":"Hajarizadeh","year":"2013","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.gtc.2015.07.002","article-title":"Epidemiology of hepatitis Cvirus: Abattle on new frontiers","volume":"44","author":"Shire","year":"2015","journal-title":"Gastroenterol. Clin. N. Am."},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.gtc.2015.07.008","article-title":"Hepatitis Cvirus: An European perspective","volume":"44","author":"Dultz","year":"2015","journal-title":"Gastroenterol. Clin. N. Am."},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1016\/S0140-6736(12)61728-0","article-title":"Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: Asystematic analysis for the global burden of disease study 2010","volume":"380","author":"Lozano","year":"2012","journal-title":"Lancet"},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1053\/j.gastro.2014.11.039","article-title":"Nonalcoholic steatohepatitis is the second leading etiology of liver disease among adults awaiting liver transplantation in the united states","volume":"148","author":"Wong","year":"2015","journal-title":"Gastroenterology"},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1053\/jhep.2003.50291","article-title":"Hepatitis Cvirus infection and incident type 2 diabetes","volume":"38","author":"Mehta","year":"2003","journal-title":"Hepatology"},{"key":"ref_187","first-page":"502","article-title":"HCV infection and diabetes mellitus: Influence of the use of finger stick devices on nosocomial transmission","volume":"25","author":"Rudoni","year":"1999","journal-title":"Diabetes Metab."},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.dld.2007.05.005","article-title":"HCV and diabetes. A two-question-based reappraisal","volume":"39","author":"Lonardo","year":"2007","journal-title":"Dig. Liver Dis."},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"7089","DOI":"10.3748\/wjg.v20.i23.7089","article-title":"Pathogenesis and significance of hepatitis C virus steatosis: An update on survival strategy of a successful pathogen","volume":"20","author":"Lonardo","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1111\/j.1478-3231.2012.02842.x","article-title":"Hyperuricaemia: Another metabolic feature affecting the severity of chronic hepatitis because of HCV infection","volume":"32","author":"Petta","year":"2012","journal-title":"Liver Int."},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1053\/j.gastro.2015.09.007","article-title":"Hepatitis C virus infection is associated with increased cardiovascular mortality: Ameta-analysis of observational studies","volume":"150","author":"Petta","year":"2016","journal-title":"Gastroenterology"},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1016\/j.cgh.2015.08.014","article-title":"Hepatocellular carcinoma from epidemiology to prevention: Translating knowledge into practice","volume":"13","author":"Singal","year":"2015","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1007\/s10620-015-3983-3","article-title":"Diabetes mellitus increases risk of hepatocellular carcinoma in chronic hepatitis C virus patients: Asystematic review","volume":"61","author":"Dyal","year":"2016","journal-title":"Dig. Dis. Sci."},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.2337\/dc05-2509","article-title":"Proinflammatory cytokines, insulin resistance, and insulin secretion in chronic hepatitis C patients: A case-control study","volume":"29","author":"Lecube","year":"2006","journal-title":"Diabetes Care"},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"2751","DOI":"10.1111\/j.1572-0241.2003.08728.x","article-title":"Tumor necrosis factor-alpha-induced insulin resistance may mediate the hepatitis C virus-diabetes association","volume":"98","author":"Knobler","year":"2003","journal-title":"Am. J. Gastroenterol."},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/j.1365-2893.2012.01644.x","article-title":"Association of suppressor of cytokine signalling 3 polymorphisms with insulin resistance in patients with chronic hepatitis C","volume":"20","author":"Zheng","year":"2013","journal-title":"J. Viral Hepat."},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1099\/vir.0.020644-0","article-title":"Hepatitis C virus core protein genotype 3a increases SOCS-7 expression through PPAR-{gamma} in Huh-7 cells","volume":"91","author":"Pazienza","year":"2010","journal-title":"J. Gen. Virol."},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1002\/hep.23031","article-title":"Sites and mechanisms of insulin resistance in nonobese, nondiabetic patients with chronic hepatitis C","volume":"50","author":"Vanni","year":"2009","journal-title":"Hepatology"},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1053\/j.gastro.2009.11.050","article-title":"Chronic hepatitis C is associated with peripheral rather than hepatic insulin resistance","volume":"138","author":"Milner","year":"2010","journal-title":"Gastroenterology"},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1212\/WNL.0000000000002291","article-title":"Hepatitis C virus infection in inclusion body myositis: A case-control study","volume":"86","author":"Uruha","year":"2016","journal-title":"Neurology"},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1053\/jhep.2001.24432","article-title":"Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity","volume":"33","author":"Adinolfi","year":"2001","journal-title":"Hepatology"},{"key":"ref_202","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/j.arcmed.2011.12.009","article-title":"Human immunodeficiency virus is the major determinant of steatosis and hepatitis C virus of insulin resistance in virus-associated fatty liver disease","volume":"42","author":"Guaraldi","year":"2011","journal-title":"Arch. Med. Res."},{"key":"ref_203","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s11739-008-0127-1","article-title":"Dysmetabolic changes associated with HCV: Adistinct syndrome?","volume":"3","author":"Lonardo","year":"2008","journal-title":"Intern. Emerg. Med."},{"key":"ref_204","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1517\/14656566.2011.597742","article-title":"Metabolic alterations and chronic hepatitis C: Treatment strategies","volume":"12","author":"Adinolfi","year":"2011","journal-title":"Expert Opin. Pharmacother."},{"key":"ref_205","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.atherosclerosis.2013.10.030","article-title":"Cardiovascular risk, lipidemic phenotype and steatosis. A comparative analysis of cirrhotic and non-cirrhotic liver disease due to varying etiology","volume":"232","author":"Loria","year":"2014","journal-title":"Atherosclerosis"},{"key":"ref_206","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1136\/gut.2009.202317","article-title":"Hepatitis Cinfection and clearance: Impact on atherosclerosis and cardiometabolic risk factors","volume":"59","author":"Mostafa","year":"2010","journal-title":"Gut"},{"key":"ref_207","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1111\/jvh.12053","article-title":"Abdominal fat interacts with PNPLA3 I148M, but not with the APOC3 variant in the pathogenesis of liver steatosis in chronic hepatitis C","volume":"20","author":"Zampino","year":"2013","journal-title":"J. Viral Hepat."},{"key":"ref_208","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1038\/ajg.2015.203","article-title":"Prevalence of cirrhosis in hepatitis Cpatients in the chronic hepatitis cohort study (CHeCS): A retrospective and prospective observational study","volume":"110","author":"Gordon","year":"2015","journal-title":"Am. J. Gastroenterol."},{"key":"ref_209","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1097\/MCG.0000000000000400","article-title":"Insulin resistance is associated with significant liver fibrosis in chronic hepatitis C patients: Asystemic review and meta-analysis","volume":"50","author":"Patel","year":"2016","journal-title":"J. Clin. Gastroenterol."},{"key":"ref_210","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1053\/j.gastro.2007.11.010","article-title":"Insulin resistance in chronic hepatitis C: Association with genotypes 1 and 4, serum HCVRNA level, and liver fibrosis","volume":"134","author":"Moucari","year":"2008","journal-title":"Gastroenterology"},{"key":"ref_211","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1111\/j.1478-3231.2010.02291.x","article-title":"Metabolic disorders associated with chronic hepatitis C: Impact of genotype and ethnicity","volume":"30","author":"Serste","year":"2010","journal-title":"Liver Int."},{"key":"ref_212","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1158\/1055-9965.EPI-08-1131","article-title":"The impact of type 2 diabetes on the development of hepatocellular carcinoma in different viral hepatitis statuses","volume":"18","author":"Wang","year":"2009","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"ref_213","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1002\/hep.26087","article-title":"Effect of type 2 diabetes on risk for malignancies includes hepatocellular carcinoma in chronic hepatitis C","volume":"57","author":"Arase","year":"2013","journal-title":"Hepatology"},{"key":"ref_214","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1002\/hep.21826","article-title":"Hepatitis C virus genotype 1b as a major risk factor associated with hepatocellular carcinoma in patients with cirrhosis: Aseventeen-year prospective cohort study","volume":"46","author":"Bruno","year":"2007","journal-title":"Hepatology"},{"key":"ref_215","doi-asserted-by":"crossref","first-page":"3410","DOI":"10.3748\/wjg.v20.i13.3410","article-title":"Chronic hepatitis C virus infection and atherosclerosis: Clinical impact and mechanisms","volume":"20","author":"Adinolfi","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"ref_216","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.atherosclerosis.2012.01.051","article-title":"Chronic HCV infection is a risk of atherosclerosis. Role of HCVand HCV-related steatosis","volume":"221","author":"Adinolfi","year":"2012","journal-title":"Atherosclerosis"},{"key":"ref_217","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1002\/hep.25508","article-title":"Carotid atherosclerosis and chronic hepatitis C: A prospective study of risk associations","volume":"55","author":"Petta","year":"2012","journal-title":"Hepatology"},{"key":"ref_218","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1016\/j.jhep.2007.01.021","article-title":"Differences and similarities in early atherosclerosis between patients with non-alcoholic steatohepatitis and chronic hepatitis Band C","volume":"46","author":"Targher","year":"2007","journal-title":"J. Hepatol."},{"key":"ref_219","doi-asserted-by":"crossref","unstructured":"Gill, K., Ghazinian, H., Manch, R., and Gish, R. (2015). Hepatitis C virus as a systemic disease: Reaching beyond the liver. Hepatol. Int., in press.","DOI":"10.1007\/s12072-015-9684-3"},{"key":"ref_220","doi-asserted-by":"crossref","unstructured":"Domont, F., and Cacoub, P. (2016). Chronic hepatitis C virus infection, a new cardiovascular risk factor?. Liver Int.","DOI":"10.1111\/liv.13064"},{"key":"ref_221","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1111\/apt.13300","article-title":"Effectiveness of sofosbuvir-based regimens in genotype 1 and 2 hepatitis C virus infection in 4026 U.S. Veterans","volume":"42","author":"Backus","year":"2015","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_222","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1001\/jama.2015.5370","article-title":"Nonalcoholic fatty liver disease: A systematic review","volume":"313","author":"Rinella","year":"2015","journal-title":"JAMA"},{"key":"ref_223","doi-asserted-by":"crossref","first-page":"10128","DOI":"10.3748\/wjg.v20.i29.10128","article-title":"Physical activity support or weight loss counseling for nonalcoholic fatty liver disease?","volume":"20","author":"Montesi","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"ref_224","doi-asserted-by":"crossref","first-page":"4597246","DOI":"10.1155\/2016\/4597246","article-title":"Nutrition and physical activity in nonalcoholic fatty liver disease","volume":"2016","author":"Oliveira","year":"2016","journal-title":"J. Diabetes Res."},{"key":"ref_225","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s11894-016-0485-1","article-title":"Targeting lifestyle behavior change in adults with NAFLD during a 20-min consultation: Summary of the dietary and exercise literature","volume":"18","author":"Hallsworth","year":"2016","journal-title":"Curr. Gastroenterol. Rep."},{"key":"ref_226","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1136\/gut.51.1.89","article-title":"Effect of weight reduction on liver histology and biochemistry in patients with chronic hepatitis C","volume":"51","author":"Hickman","year":"2002","journal-title":"Gut"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/17\/3\/355\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T19:20:27Z","timestamp":1760210427000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/17\/3\/355"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3,9]]},"references-count":226,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2016,3]]}},"alternative-id":["ijms17030355"],"URL":"https:\/\/doi.org\/10.3390\/ijms17030355","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,9]]}}}